Loading
Latest filing published 01 Apr 2022 for Aarti Drugs Limited, €73k.
Harshit Manilal Savla (chief executive) discloses dealings in Aarti Drugs Limited to SEBI (PIT + SAST). We count 2 filings; the first trade dates from 18 May 2021 and the latest from 31 March 2022.
No open-market sale appears; the market trades are 1 purchase worth €73k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Since January 2022: 1 purchase and no sales on the market.
Most recently, on 1 April 2022, the filings show an open-market purchase worth €73k in Aarti Drugs Limited. This summary is built from SEBI (PIT + SAST) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations